T-cell receptor CDR3 size distribution analysis to evaluate specific T-cell response to cancer vaccines

International Journal of Cancer

Volumn 71, Issue 6, 1997, Pages 972-977

  Farace, Françoise ^a   Angevin, Eric ^a   Polllion, Isabelle ^a   Leboullaire, Christophe ^a   Ferir, Ghislaine ^a   Elias, Dominique ^a   Escudier, Bernard ^a   Triebel, Frédéric ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER VACCINE; INTERLEUKIN 2; T LYMPHOCYTE RECEPTOR;

ADULT; ARTICLE; CASE REPORT; CELL CLONE; COLORECTAL CARCINOMA; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; FEMALE; HUMAN CELL; IMMUNE RESPONSE; INTRADERMAL DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

ADENOCARCINOMA; CANCER VACCINES; COLONIC NEOPLASMS; FEMALE; HUMANS; IMMUNOGLOBULIN VARIABLE REGION; LIVER NEOPLASMS; MIDDLE AGED; T-LYMPHOCYTES;

EID: 0030969551     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970611)71:6<972::AID-IJC11>3.0.CO;2-8     Document Type: Article

References (21)

1. BRICHARD, V., VAN PEL, A., WÖLFEL, T., WÖLFEL, C., PLAEN, E.D., LETHÉ, B., COULIE, P. and BOON, T., The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J. exp. Med., 178, 489-495 (1993).
2. CAIGNARD, A., DIETRICH, P.Y., MORAND, V., LIM, A., PANNETIER, C., LERIDANT, A.M., HERCEND, T., EVEN, J., KOURILSKY, P. and TRIEBEL, F., Evidence for T-cell clonal expansion in a patient with squamous cell carcinoma of the head and neck. Cancer Res., 54, 1-6 (1994).
3. CAIGNARD, A., GUILLARD, M., GAUDIN, C., ESCUDIRE, B., TRIEBEL, F. and DIETRICH, P-Y., In situ demonstration of renal-cell-carcinoma-specific T-cell clones. Int. J. Cancer, 66, 564-570 (1996).
4. CHOMCZYNSKI, P. and SACCHI, N., Single step of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162, 156-162 (1987).
5. COCHET, M., PANNETIER, C., REGNAULT, A., DARCHE, S., LECLERC, C. and KOURILSKY, P., Molecular detection and in vivo analysis of the specific T cell response to a protein antigen. Europ. J. Immunol., 22, 2639-2647 (1992).
6. COULIE, P.G., BRICHARD, V., VAN PEL, A., WÖLFEL, T., SCHNEIDER, J., TRAVERSARI, C., MATTEI, S., PLAEN, E.D., LURQUIN, C., SZIKORA, J.P., RENAULD, J.C. and BOON, T., A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J. exp. Med., 180, 35-42 (1994).
7. COX, A.L., SKIPPER, J., CHEN, Y., HENDERSON, R.A., DARROW, T.L., SHABANOWITZ, J., ENGELHARD, V.H., HUNT, D.F. and SLINGLUFF, C.L., Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines. Science, 264, 716-719 (1994).
8. EVEN, J., LIM, A., PUISIEUX, I., FERRADINI, L., DIETRICH, P.Y., TOUBERT, A., HERCEND, T., TRIEBEL, F., PANNETIER, C. and KOURILSKY, P., T-cell repertoires in healthy and diseased human tissues analysed by T-cell receptor β-chain CDR3 size determination; evidence for oligoclonal expansions in tumours and inflammatory diseases. Res. Immunol., 146, 65-80 (1995).
9. FARACE, F., ORLANDUCCI, F., DIETRICH, P.Y., GAUDIN, C., ANGEVIN, E., COURTIER, M.H., BAYLE, C., HERCEND, T. and TRIEBEL, F., T cell repertoire in patients with B-chronic lymphocytic leukemia: evidence for multiple in vivo T cell clonal expansions. J. Immunol., 153, 4281-4290 (1994).
10. GENEVÉE, C., DIU, A., NIERAT, J., CAIGNARD, A., DIETRICH, P.Y., FERRADINI, L., ROMAN-ROMAN, S., TRIEBEL, F. and HERCEND, T., An experimentally validated panel of subfamily-specific oligonucleotide primers (Vα1-w29/ Vβ1-w24) for the study of human T cell receptor variable V gene segment usage by polymerase chain reaction. Europ. J. Immunol., 22, 1261-1269 (1992).
11. JORGENSEN, J.L., ESSER, U., FAZEKAS DE ST. GROTH, B., REAY, P.A. and DAVIS, M.M., Mapping T-cell receptor-peptide contacts by variant peptide immunization of single-chain transgenics. Nature (Lond.), 355, 224-230 (1992).
12. KAWAKAMI, Y., ELIYAHU, S., DELGADO, C.H., ROBBINS, P.F., RIVOLTINI, L., TOPALIAN, S.L., MIKI, T. and ROSENBERG, S.A., Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor. Proc. nat. Acad. Sci. (Wash.), 91, 3515-3519 (1994a).
13. KAWAKAMI, Y., ELIYAHU, S., SAKAGUCHI, K., ROBBINS, P.R., RIVOLTINI, L., YANNELLI, J.R., APPELLA, E. and ROSENBERG, S.A., Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes. J. exp. Med., 180, 347-352 (1994b).
14. KUMAR, A., FARACE, F., GAUDIN, C. and TRIEBEL, F., Clonal T cell expansion induced by interleukin-2 therapy in blood and tumors. J. clin. Invest., 97, 1219-1226 (1996).
15. MACKENSEN, A., CARCELAIN, G., VIEL, S., RAYNAL, M.C., MICHALAKI, H., TRIEBEL, F., BOSQ, J. and HERCEND, T., Direct evidence to support the immunosurveillance concept in a human regressive melanoma. J. clin. Invest., 93, 1397-2002 (1994).
16. MACKENSEN, A., FERRADINI, L., CARCELAIN, G., TRIEBEL, F., FAURE, F., VIEL, S. and HERCEND, T., Evidence for in situ amplification of cytotoxic T-lymphocytes with antitumor activity in a human regressive melanoma. Cancer Res., 53, 3569-3573 (1993).
17. PANNETIER, C., COCHET, M., DARCHE, S., CASROUGE, A., ZOLLER, M. and KOURILSKY, P. The sizes of the CDR3 hypervariable regions of the marine T-cell receptor β chains vary as a function of the recombined germ-line segments. Proc. nat. Acad. Sci. (Wash.), 90, 2472-2477 (1993).
18. PETERS, L.C., BRANDHORST, J.S. and HANNA, M.G. JR., Preparation of immuno-therapeutic autologous tumor cell vaccines from solid tumors. Cancer Res., 39, 1353-1360 (1979).
19. PUISIEUX, I., EVEN, J., PANNETIER, C., JOTEREAU, F., FAVROT, M. and KOURILSKY, P., Oligoclonality of tumor-infiltrating lymphocytes from human melanomas. J. Immunol., 153, 2807-2818 (1994).
20. VAN DER BRUGGEN, P., TRAVERSARI, C., CHOMEZ, P., LURQUIN, C., DE PLAEN, E., VAN DEN EYNDE, B., KNUTH, A. and BOON, T., A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science, 254, 1643-1647 (1991).
21. WÖLFEL, T., VAN PEL, A., BRICHARD, V., SCHNEIDER, J., SELIGER, B., MEYER ZUM BUSCHENFELDE, K.H. and BOON, T., Two tyrosinase nonapeptides recognized on HLA-A2 melanomas by autologous cytolytic T lymphocytes. Europ. J. Immunol., 24, 759-764 (1994).